StatLab Medical Products (StatLab) buys Myr Medical Specialties, SL (Myr), a Spanish manufacturer of histology equipment. This acquisition strengthens StatLab’s capabilities, expanding its portfolio and consolidating its international presence in key markets.
Myr, founded 36 years ago by Francisco (Paco) Ruiz and based in Tarragona, Spain, specializes in the design and manufacture of equipment for processing, embedding, cutting and dyeing tissues. Its global network of distributors has been key to positioning itself as a benchmark in the sector.
“With the addition of Myr, we are diversifying our offering and consolidating our position in key European markets,” he said. Sung-Dae Hong, CEO of StatLab.
New opportunities for expansion and collaboration
The alliance between the two companies opens new distribution channels in emerging markets and strengthens operations in Europe. Myr brings an advanced manufacturing facility as well as a team of experts that is now part of StatLab.
“The acquisition of Myr not only expands our capabilities, but also enables investments to continue developing innovative solutions,” Hong added.
Francisco Ruiz, founder of Myr, highlighted the potential of the union: “Working together with StatLab is a unique opportunity to expand our brand and bring our products to more markets.”
Impact on emerging markets and European consolidation
The agreement also seeks to leverage StatLab’s expertise in developing markets. The addition of the Diapath and CellPath brands to the expanded portfolio strengthens its reach in key sectors.
“The shared vision of both companies ensures that we will continue to offer high-quality products that meet customer needs,” Ruiz concluded.
With this integration, StatLab demonstrates its commitment to innovation and strategic growth, consolidating its position as a global leader in medical diagnostic equipment.
